Gsa Capital Partners LLP Phio Pharmaceuticals Corp. Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
$1.87 - $2.8 $247,462 - $370,532
-132,333 Closed
0 $0
Q1 2021

May 10, 2021
BUY
$2.48 - $4.05 $76,711 - $125,274
30,932 Added 30.5%
132,333 $355,000
Q4 2020

Feb 03, 2021
BUY
$2.01 - $3.32 $161,047 - $266,008
80,123 Added 376.55%
101,401 $273,000
Q3 2020

Nov 06, 2020
BUY
$1.95 - $2.94 $41,492 - $62,557
21,278 New
21,278 $46,000

Others Institutions Holding PHIO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Phio Pharmaceuticals Corp.

PHIO Quotes by TradingView
  • Ticker PHIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,658,700
  • Market Cap $25M
  • Description
  • Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...
More about PHIO
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email